NCT06202014 2024-01-19
Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
Clinical Trials
12 trialsNCT05415917 2023-08-22
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy
Rutgers, The State University of New Jersey
Phase 2 Unknown
NCT03775525 2022-12-23
GEN602
Genzada Pharmaceuticals USA, Inc.
Phase 1 Unknown
NCT05566743 2022-10-04
A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas
Menoufia University
Phase 2 Unknown
NCT04089150 2021-10-22
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
NCT03959150 2021-04-30
Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer
Ruijin Hospital
Phase 2/3 Unknown
NCT01494155 2021-02-02
Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT01077427 2017-11-17
HEAT
Klinikum der Universitaet Muenchen, Grosshadern
Phase 3 Unknown
NCT01796782 2013-02-22
QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer
Fudan University
Phase 2 Unknown
NCT00440167 2012-07-09
Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Ludwig-Maximilians - University of Munich
Phase 3 Unknown
NCT00658840 2012-04-03
Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma
National Cancer Center, Korea
Phase 2 Unknown
NCT01333332 2011-04-11
Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
University of Virginia
Phase 2 Unknown